Yi K - Search Results

1

A LIGHTFUL nanomedicine overcomes EGFR-mediated drug resistance for enhanced tyrosine-kinase-inhibitor-based hepatocellular carcinoma therapy.

Yi K, Kong H, Zheng C, Zhuo C, Jin Y, Zhong Q, Mintz RL, Ju E, Wang H, Lv S, Lao YH, Tao Y, Li M. Yi K, et al. Biomaterials. 2023 Nov;302:122349. doi: 10.1016/j.biomaterials.2023.122349. Epub 2023 Oct 6. Biomaterials. 2023. PMID: 37844429

2

Coassembly of nucleus-targeting gold nanoclusters with CRISPR/Cas9 for simultaneous bioimaging and therapeutic genome editing.

Tao Y, Yi K, Hu H, Shao D, Li M. Tao Y, et al. Among authors: yi k. J Mater Chem B. 2021 Jan 7;9(1):94-100. doi: 10.1039/d0tb01925a. Epub 2020 Nov 21. J Mater Chem B. 2021. PMID: 33220661

3

Nanotheranostics for the Management of Hepatic Ischemia-Reperfusion Injury.

Guan Y, Yao W, Yi K, Zheng C, Lv S, Tao Y, Hei Z, Li M. Guan Y, et al. Among authors: yi k. Small. 2021 Jun;17(23):e2007727. doi: 10.1002/smll.202007727. Epub 2021 Apr 14. Small. 2021. PMID: 33852769 Review.

4

3D Printed Bioceramic Scaffolds as a Universal Therapeutic Platform for Synergistic Therapy of Osteosarcoma.

Dang W, Yi K, Ju E, Jin Y, Xu Y, Wang H, Chen WC, Wang K, Wang Y, Tao Y, Li M. Dang W, et al. Among authors: yi k. ACS Appl Mater Interfaces. 2021 Apr 28;13(16):18488-18499. doi: 10.1021/acsami.1c00553. Epub 2021 Apr 15. ACS Appl Mater Interfaces. 2021. PMID: 33856761

5

Applications of Nanobiomaterials in the Therapy and Imaging of Acute Liver Failure.

Jin Y, Wang H, Yi K, Lv S, Hu H, Li M, Tao Y. Jin Y, et al. Among authors: yi k. Nanomicro Lett. 2020 Nov 19;13(1):25. doi: 10.1007/s40820-020-00550-x. Nanomicro Lett. 2020. PMID: 34138224 Free PMC article. Review.

6

Noble metal-molybdenum disulfide nanohybrids as dual fluorometric and colorimetric sensor for hepatitis B virus DNA detection.

Tao Y, Lao YH, Yi K, Xu Y, Wang H, Shao D, Wang J, Li M. Tao Y, et al. Among authors: yi k. Talanta. 2021 Nov 1;234:122675. doi: 10.1016/j.talanta.2021.122675. Epub 2021 Jun 29. Talanta. 2021. PMID: 34364475

7

Advanced Nanotheranostics of CRISPR/Cas for Viral Hepatitis and Hepatocellular Carcinoma.

Kong H, Ju E, Yi K, Xu W, Lao YH, Cheng D, Zhang Q, Tao Y, Li M, Ding J. Kong H, et al. Among authors: yi k. Adv Sci (Weinh). 2021 Dec;8(24):e2102051. doi: 10.1002/advs.202102051. Epub 2021 Oct 19. Adv Sci (Weinh). 2021. PMID: 34665528 Free PMC article. Review.

8

Combatting Helicobacter pylori with oral nanomedicines.

Qin Y, Lao YH, Wang H, Zhang J, Yi K, Chen Z, Han J, Song W, Tao Y, Li M. Qin Y, et al. Among authors: yi k. J Mater Chem B. 2021 Dec 15;9(48):9826-9838. doi: 10.1039/d1tb02038b. J Mater Chem B. 2021. PMID: 34854456 Review.

9

CRISPR-Cas12a-regulated DNA adsorption and metallization on MXenes as enhanced enzyme mimics for sensitive colorimetric detection of hepatitis B virus DNA.

Tao Y, Yi K, Wang H, Kim HW, Li K, Zhu X, Li M. Tao Y, et al. Among authors: yi k. J Colloid Interface Sci. 2022 May;613:406-414. doi: 10.1016/j.jcis.2022.01.038. Epub 2022 Jan 10. J Colloid Interface Sci. 2022. PMID: 35042038

10

Delivery of Stem Cell Secretome for Therapeutic Applications.

Li F, Zhang J, Yi K, Wang H, Wei H, Chan HF, Tao Y, Li M. Li F, et al. Among authors: yi k. ACS Appl Bio Mater. 2022 May 16;5(5):2009-2030. doi: 10.1021/acsabm.1c01312. Epub 2022 Mar 14. ACS Appl Bio Mater. 2022. PMID: 35285638 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,855 results

Search Page

Filters